The proliferation of pancreatic cancer cells was notably enhanced by CASC19 overexpression (Fig. 2D) and reduced by downregulation of CASC19, as measured by MTT assay (Fig. 2E). The gene discussed is CASC19; the disease is pancreatic neoplasm.